PRESTIGE CONSUMER HEALTHCARE INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 8.50 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-06
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 8.50K shares.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 0.00 shares.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2023-12-31 was 0.00 shares.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2026 was 3.70K shares.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 2.80K shares, a 40.00% increase from fiscal 2023.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 2.00K shares, a 76.47% decline from fiscal 2022.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 8.50K shares, a 38.85% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 8.50K shares 10-Q · filed 2026-08-06 | 8.50K shares derived: sum of 2 quarters · filed 2026-08-06 | |||
| 2026-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | 3.70K shares 10-K · filed 2026-05-14 | |||
| 2025-12-31 | 3.70K shares 10-Q · filed 2026-02-05 | ||||
| 2024-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-14 | 1.10K shares derived: sum of 3 quarters · filed 2026-05-14 | 2.80K shares 10-K · filed 2026-05-14 | |
| 2023-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | 1.10K shares derived: sum of 2 quarters · filed 2025-02-06 | 2.80K shares 10-Q · filed 2025-02-06 | 4.00K shares derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-09-30 | 1.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | 2.80K shares 10-Q · filed 2024-11-07 | 4.00K shares derived: sum of 3 quarters · filed 2025-05-09 | ||
| 2023-06-30 | 1.70K shares 10-Q · filed 2024-08-08 | 2.90K shares derived: sum of 2 quarters · filed 2025-05-09 | |||
| 2023-03-31 | 1.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-09 | 2.00K shares 10-K · filed 2025-05-09 | 800.00 shares 10-K · filed 2023-05-05 | ||
| 2022-12-31 | 800.00 shares 10-Q · filed 2024-02-08 | ||||
| 2022-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2024-05-15 | 100.00 shares derived: sum of 3 quarters · filed 2024-05-15 | 8.50K shares 10-K · filed 2024-05-15 | |
| 2021-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-02 | 100.00 shares derived: sum of 2 quarters · filed 2023-02-02 | 8.50K shares 10-Q · filed 2023-02-02 | 22.40K shares derived: sum of 4 quarters · filed 2023-05-05 | |
| 2021-09-30 | 100.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-03 | 8.50K shares 10-Q · filed 2022-11-03 | 22.40K shares derived: sum of 3 quarters · filed 2023-05-05 | 22.40K shares derived: sum of 4 quarters · filed 2023-05-05 | |
| 2021-06-30 | 8.40K shares 10-Q · filed 2022-08-04 | 22.30K shares derived: sum of 2 quarters · filed 2023-05-05 | 22.30K shares derived: sum of 3 quarters · filed 2023-05-05 | ||
| 2021-03-31 | 13.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-05 | 13.90K shares derived: sum of 2 quarters · filed 2023-05-05 | 13.90K shares 10-K · filed 2023-05-05 | ||
| 2020-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-03 | 0.00 shares 10-Q · filed 2022-02-03 | |||
| 2020-09-30 | 0.00 shares 10-Q · filed 2021-11-04 | ||||
| 2020-03-31 | 100.00K shares 10-K · filed 2022-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |